Breast Cancer Stem Cells

Breast cancer is marked mutually of the leading causes of malignancy-related morbidities worldwide. In spite of aggressive interventions, the inevitableness of relapse and metastasis severely impede survival rates. Mounting proof highlight the insidious role of cancer stem cells (CSCs), a little but important population of undifferentiated cells that drive growth progression, spread and resistance to standard therapy. The nature and significance of breast CSCs remains poorly understood, and even controversial by several researchers. This review discusses the origins, biomarkers, signalling pathways, restrictive mechanisms, and targeted therapy of breast CSCs

However, despite offered interventions, patients below remission should still develop carcinoma relapse and metastasis. Accumulating proof suggests that the underlying presence of a tiny low universe of undifferentiated cells, termed carcinoma stem cells (BCSCs), area unit presumably make to growth progression, spreading and resistance to traditional therapy.

 

    Related Conference of Breast Cancer Stem Cells

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Breast Cancer Stem Cells Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in